Pathology Doctors in Woodstock, IL Accepting Medicare

3 Pathology doctors found. Showing 1 - 3

Wendy L. Ward, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 3701 Doty Rd, Centegra Memorial Medical Center / Pathology Department, Woodstock, IL 60098 Phone: 815-344-5555

Rosanne Fitko, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 3701 Doty Rd, Lake / Mchenry Pathology Associates, Ltd., Woodstock, IL 60098 Phone: 815-344-5555

Rakhshan Naqvi, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: Centegra Memorial Medical Center / Pahology Department, 3701 Doty Road, Woodstock, IL 60098 Phone: 815-344-5555

News Archive

HHS honors UNTHSC, Brookdale Senior Living with $7.3M Health Care Innovation award

The UNT Health Science Center and Brookdale Senior Living, the largest senior living community operator in the country, recently were awarded a $7.3 million Health Care Innovation award from the U.S. Department of Health and Human Services for a program designed to reduce hospital re-admissions of residents in assisted-living situations.

ESMO creates new Community Oncology Working Group to ensure best standards of care

Receiving a cancer diagnosis is a devastating experience. Still under the shock of the bad news, patients must make many choices including who to turn to for advice and treatment, with the possibility to choose among a comprehensive cancer center, a university hospital or a community oncology hospital.

Pension and health costs may be higher than estimated in low-mortality countries

A new study by demographer John Bongaarts, Population Council Vice President and Distinguished Scholar, has found that mortality projections from most low-mortality countries are more pessimistic than they should be.

Glide Pharma to utilize $4.3M funding for progressing octreotide programme into clinical development

Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million.

Widespread HCV testing and treatment strategy in U.S. prisons improves outcomes

At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.

Read more Medical News

› Verified 8 days ago